Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This is a randomized, balanced, open Label, two-treatment, two-period, two-sequence, single
dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence
between Test Product and the corresponding Reference Product under fed condition in normal,
healthy, adult, male and female human subjects.